- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6890
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma ; volume:14 ; number:1 ; day:3 ; month:4 ; year:2014 ; pages:1-7 ; date:12.2014
BMC clinical pathology ; 14, Heft 1 (3.4.2014), 1-7, 12.2014
- Creator
-
von Klot, Christoph-A
- Contributor
-
Kramer, Mario W.
Peters, Inga
Hennenlotter, Joerg
Abbas, Mahmoud
Scherer, Ralph
Herrmann, Thomas RW
Stenzl, Arnulf
Kuczyk, Markus A.
Serth, Juergen
Merseburger, Axel S.
SpringerLink (Online service)
- DOI
-
10.1186/1472-6890-14-15
- URN
-
urn:nbn:de:1111-2016071636514
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- von Klot, Christoph-A
- Kramer, Mario W.
- Peters, Inga
- Hennenlotter, Joerg
- Abbas, Mahmoud
- Scherer, Ralph
- Herrmann, Thomas RW
- Stenzl, Arnulf
- Kuczyk, Markus A.
- Serth, Juergen
- Merseburger, Axel S.
- SpringerLink (Online service)
Other Objects (12)
A Synthetic Galectin Mimic
A Synthetic Galectin Mimic
Heteromultivalente Glykomakromoleküle Targeting Galectin-3
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3
Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury
Design and characterization of galectin-3 fusion proteins and novel multivalent galectin-3 ligands
The Evaluation of Glyceryl C3‐Azolyl‐Thiogalactosides as Galectin‐1 and Galectin‐3 Ligands
Changes in the expression and subcellular distribution of galectin-3 in clear cell renal cell carcinoma
Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study
Galectin-3 als Biomarker bei Vorhofflimmern
Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3
A Synthetic Galectin Mimic
A Synthetic Galectin Mimic
Heteromultivalente Glykomakromoleküle Targeting Galectin-3
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3
Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury
Design and characterization of galectin-3 fusion proteins and novel multivalent galectin-3 ligands
The Evaluation of Glyceryl C3‐Azolyl‐Thiogalactosides as Galectin‐1 and Galectin‐3 Ligands
Changes in the expression and subcellular distribution of galectin-3 in clear cell renal cell carcinoma
Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study
Galectin-3 als Biomarker bei Vorhofflimmern
Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3
A Synthetic Galectin Mimic
A Synthetic Galectin Mimic
Heteromultivalente Glykomakromoleküle Targeting Galectin-3
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3
Pharmacological treatment with galectin-1 protects against renal ischaemia-reperfusion injury
Design and characterization of galectin-3 fusion proteins and novel multivalent galectin-3 ligands
The Evaluation of Glyceryl C3‐Azolyl‐Thiogalactosides as Galectin‐1 and Galectin‐3 Ligands
Changes in the expression and subcellular distribution of galectin-3 in clear cell renal cell carcinoma
Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study
Galectin-3 als Biomarker bei Vorhofflimmern